Multilayer Biocompatible Coating for Implantable IOP Sensors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for monitoring intraocular pressure (IOP) in glaucoma patients are inadequate due to reliance on episodic measurements, leading to incomplete data and poor compliance with medication protocols, which can result in ineffective treatment and potential progression of the disease.
Innovation Solution
Development of an implantable device with a biocompatible coating for intraocular pressure sensors that allows for continuous monitoring of IOP, featuring a multilayer coating with a diffusion regulatory mechanism to release anti-inflammatory and anticlotting agents, and a wireless communication system for real-time data transmission.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a coating is applied to the implantable device, then biocompatibility and reduced fibrotic response are improved, but device complexity increases
Solution Approach 1:
The coating is divided into multiple layers with distinct functions: an inner layer providing biocompatibility and anti-fibrotic properties, and an outer layer providing anti-inflammatory and anticlotting properties. This segmentation allows each layer to be optimized for its specific function while working together to achieve overall biocompatibility.
Solution Approach 2:
The coating uses composite material structure combining different polymeric materials with specific properties. The inner layer uses materials with controlled cross-link density for biocompatibility, while the outer layer uses materials with different cross-link density for anti-inflammatory and anticlotting functions, creating a composite coating system.
2Duration of action of moving object
If a multilayer coating with diffusion regulatory mechanism is used, then controlled release of agents is improved, but manufacturing precision requirements increase
Solution Approach 1:
The coating achieves controlled release by changing the cross-link density parameter across different layers. The inner layer has a first cross-link density that controls initial agent release, while the outer layer has a second cross-link density that regulates sustained release over time. This parameter variation enables prolonged therapeutic action.
Solution Approach 2:
Different regions of the coating have different cross-link densities tailored to local functional requirements. The inner layer near the device surface has one cross-link density for immediate biocompatibility, while the outer layer has a different cross-link density for sustained drug release, creating local quality variations that achieve temporal control.
3Duration of action of moving object
If the outer layer has lower cross-link density than the inner layer, then sustained release and hydrophilicity are improved, but mechanical strength may be reduced
Solution Approach 1:
The coating is segmented into inner and outer layers with different mechanical and functional properties. The inner layer with higher cross-link density provides structural support and strength, while the outer layer with lower cross-link density provides sustained release and hydrophilicity, allowing the system to achieve both strength and prolonged action.
Solution Approach 2:
The composite coating structure combines materials with different cross-link densities to achieve complementary properties. The high cross-link density inner layer contributes mechanical strength, while the low cross-link density outer layer enables sustained release and hydrophilic interactions, creating a composite system where the whole achieves properties neither layer could provide alone.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables continuous, accurate monitoring of IOP, improving patient compliance and treatment efficacy by providing real-time data to caregivers, and supporting better management of glaucoma treatment outcomes.
Implementation Method 1
a diffusion regulatory mechanism to release anti-inflammatory and anticlotting agents
Data Source
AI summary
Intraocular pressure sensors, systems, and methods of use. Implantable intraocular pressure sensing devices that are hermetically sealed and adapted to wirelessly communicate with an external device. The implantable devices can include a hermetically sealed housing, the hermetically sealed housing including therein: an antenna in electrical communication with a rechargeable power source, the rechargeable power source in electrical communication with an ASIC, and the ASIC in electrical communication with a pressure sensor.


